Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check5 days agoChange DetectedThis update refreshes the website’s version/revision footer from v3.5.2 to v3.5.3 without changing the study record content.SummaryDifference0.1%

- Check12 days agoChange DetectedThe website revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew and removed entry dates were added to the study record, with the latest update posted on 2026-03-27.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision log updated: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.3 has been added and v3.4.2 has been removed, updating the page’s revision label.SummaryDifference0.1%

- Check62 days agoChange DetectedStudy locations updated to 7 sites. Some site contacts and location details were removed (e.g., Allentown, PA / Lehigh Valley contact information).SummaryDifference0.7%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.